Ohad Karneili

Chief Executive Officer • Adva Biotechnology

Ohad is ADVA Biotechnology’s Founder and CEO and A well-known international expert in cell therapy. Dr. Karnieli is the founder and former CEO of Atvio Biotech, a leading Innovation center for cell & gene therapy that was sold to Orgenesis Inc. in 2018. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP of the medical device at Goji solutions. Dr. Karnieli served as the chair of the process & product development committee of the International Society for Cellular Therapies, as an expert member in the ISO TC276 Biotechnology standard committee and was the former chair of the science and technology committee of the Alliance for Regenerative Medicine.